-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
periglaucine A
Category | Hepatitis B Virus (HBV) |
CAS | 1025023-04-4 |
Description | Periglaucine A is a natural alkaloid extracted from the aerial parts of Pericampylus glaucus, it can inhibit hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. |
Product Information
Synonyms | periglaucine A;1025023-04-4;(1S,11S,13S,14R,15R)-14,15-Dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.111,14.01,13.02,10.04,8]henicosa-2,4(8),9-trien-16-one;CHEBI:66731;HY-N3094;AKOS032961999;CS-0023212;Q27135353; |
IUPAC Name | (1S,11S,13S,14R,15R)-14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.111,14.01,13.02,10.04,8]henicosa-2,4(8),9-trien-16-one |
Molecular Weight | 373.40 |
Molecular Formula | C20H23NO6 |
Canonical SMILES | CO[C@]12[C@@]34[C@](CC([C@H]2OC)=O)(CCN4C)C5=CC(OCO6)=C6C=C5[C@](O1)([H])C3 |
InChI | InChI=1S/C20H23NO6/c1-21-5-4-18-8-13(22)17(23-2)20(24-3)19(18,21)9-16(27-20)11-6-14-15(7-12(11)18)26-10-25-14/h6-7,16-17H,4-5,8-10H2,1-3H3/t16-,17+,18-,19-,20-/m0/s1 |
InChIKey | QJDYNQYLCIPODD-WPVAHCMFSA-N |
Boiling Point | 509.5±50.0°C (Predicted) |
Purity | >98% |
Density | 1.43±0.1 g/cm3(Predicted) |
Appearance | Powder |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |